Spontaneous and vaccine-induced clearance of Mus musculus papillomavirus 1 infection

Rosie T. Jiang, Joshua W. Wang, Shiwen Peng, Tsui Chin Huang, Chenguang Wang, Fabiana Cannella, Yung Nien Chang, Raphael P. Viscidi, Simon R.A. Best, Chien Fu Hung, Richard B.S. Roden

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)


Mus musculus papillomavirus 1 (MmuPV1/MusPV1) induces persistent papillomas in immunodeficient mice but not in common laboratory strains. To facilitate the study of immune control, we sought an outbred and immunocompetent laboratory mouse strain in which persistent papillomas could be established. We found that challenge of SKH1 mice (Crl:SKH1-Hrhr) with MmuPV1 by scarification on their tail resulted in three clinical outcomes: (i) persistent (>2-month) papillomas (~20%); (ii) transient papillomas that spontaneously regress, typically within 2 months (~15%); and (iii) no visible papillomas and viral clearance (~65%). SKH1 mice with persistent papillomas were treated by using a candidate preventive/therapeutic naked-DNA vaccine that expresses human calreticulin (hCRT) fused in frame to MmuPV1 E6 (mE6) and mE7 early proteins and residues 11 to 200 of the late protein L2 (hCRTmE6/mE7/mL2). Three intramuscular DNA vaccinations were delivered biweekly via in vivo electroporation, and both humoral and CD8 T cell responses were mapped and measured. Previously persistent papillomas disappeared within 2 months after the final vaccination. Coincident virologic clearance was confirmed by in situ hybridization and a failure of disease to recur after CD3 T cell depletion. Vaccination induced strong mE6 and mE7 CD8+ T cell responses in all mice, although they were significantly weaker in mice that initially presented with persistent warts than in those that spontaneously cleared their infection. A human papillomavirus 16 (HPV16)-targeted version of the DNA vaccine also induced L2 antibodies and protected mice from vaginal challenge with an HPV16 pseudovirus. Thus, MmuPV1 challenge of SKH1 mice is a promising model of spontaneous and immunotherapydirected clearances of HPV-related disease.

Original languageEnglish
Article numbere00699-17
JournalJournal of Virology
Issue number15
Publication statusPublished - Aug 1 2017


  • DNA vaccines
  • Mouse model
  • Neutralizing antibodies
  • Papillomavirus
  • SKH-1 mice
  • T cells

ASJC Scopus subject areas

  • Immunology
  • Virology


Dive into the research topics of 'Spontaneous and vaccine-induced clearance of Mus musculus papillomavirus 1 infection'. Together they form a unique fingerprint.

Cite this